13,14-<wbr/>dihydro-<wbr/>15-<wbr/>keto-<wbr/>tetranor Prostaglandin D<sub>2</sub>

13,14-dihydro-15-keto-tetranor Prostaglandin D2

CAT N°: 13100
Price:

From 157.00 133.45

A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the ?-terminus and oxidation of the terminal ?-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View